SEC Tracker
Get the app
Person · CIK 1756253

Mark Douglas Smith

Director at Jazz Pharmaceuticals, Phreesia and Teladoc Health

Source: Forms 3, 4, 5 and 144 on SEC EDGAR

Sold on Form 4$1.9M
Noticed on Form 144$2.8M
Bought on Form 4$28K
Companies3

Holdings now

As reported after the latest Form 3, 4 or 5 at each company.

How these figures work

Options and RSUs are from the latest filing that lists them; earlier grants may also be held. Holdings can be out of date when a person stops filing.

CompanySecurityHeldShares or unitsAs of
Jazz Pharmaceuticals JAZZOrdinary SharesDirectly9,579Aug 31, 2026 · Filing · EDGAR
Jazz Pharmaceuticals JAZZNon-Qualified Stock Option (right to buy)
exercise $170.74, expires Feb 24, 2031, into Ordinary Shares
Directly6,475Feb 25, 2021 · Filing · EDGAR
Phreesia PHRCommon StockDirectly56,643Jun 24, 2026 · Filing · EDGAR
Phreesia PHRStock Option
exercise $4.71, expires Sep 4, 2028, into Common Stock
Directly51,193Jul 2, 2025 · Filing · EDGAR
Teladoc Health TDOCCommon StockDirectly8,355Aug 15, 2024 · Filing · EDGAR
Teladoc Health TDOCRestricted Stock UnitsDirectly3,012May 28, 2020 · Filing · EDGAR
Teladoc Health TDOCRestricted Stock Units
into Common Stock
Directly30,441May 21, 2026 · Filing · EDGAR

Sold and noticed by quarter

Mark Douglas Smith: dollars sold on Form 4 and noticed on Form 144 per quarter, Q1 2021 to Q4 2026$858K$0Q1 2021: notice not machine-readableQ1 2021: $315K sold on Form 4Q2 2021: $0 noticed on Form 144Q2 2021: $0 sold on Form 4Q3 2021: $0 noticed on Form 144Q3 2021: $0 sold on Form 4Q4 2021: notice not machine-readableQ4 2021: $51K sold on Form 4Q1 2022: $0 noticed on Form 144Q1 2022: $0 sold on Form 4Q2 2022: $0 noticed on Form 144Q2 2022: $0 sold on Form 4Q3 2022: notice not machine-readableQ3 2022: $166K sold on Form 4Q4 2022: notice not machine-readableQ4 2022: $65K sold on Form 4Q1 2023: $0 noticed on Form 144Q1 2023: $0 sold on Form 4Q2 2023: $226K noticed on Form 144Q2 2023: $215K sold on Form 4Q3 2023: $346K noticed on Form 144Q3 2023: $171K sold on Form 4Q4 2023: $0 noticed on Form 144Q4 2023: $50K sold on Form 4Q1 2024: $0 noticed on Form 144Q1 2024: $0 sold on Form 4Q2 2024: $0 noticed on Form 144Q2 2024: $0 sold on Form 4Q3 2024: $516K noticed on Form 144Q3 2024: $175K sold on Form 4Q3 2024: $28K boughtQ4 2024: $0 noticed on Form 144Q4 2024: $0 sold on Form 4Q1 2025: $0 noticed on Form 144Q1 2025: $0 sold on Form 4Q2 2025: $0 noticed on Form 144Q2 2025: $0 sold on Form 4Q3 2025: $621K noticed on Form 144Q3 2025: $203K sold on Form 4Q4 2025: $0 noticed on Form 144Q4 2025: $0 sold on Form 4Q1 2026: $0 noticed on Form 144Q1 2026: $0 sold on Form 4Q2 2026: $267K noticed on Form 144Q2 2026: $267K sold on Form 4Q3 2026: $858K noticed on Form 144Q3 2026: $0 sold on Form 4Q4 2026: $0 noticed on Form 144Q4 2026: $0 sold on Form 4Q1 2021Q2 2022Q3 2023Q4 2024Q1 2026

Sold (Form 4) Noticed (Form 144) Bought (Form 4)

Quarterly totals as a table
QuarterSold (Form 4)Noticed (Form 144)Bought (Form 4)
Q3 2026—$858K—
Q2 2026$267K$267K—
Q3 2025$203K$621K—
Q3 2024$175K$516K$28K
Q4 2023$50K——
Q3 2023$171K$346K—
Q2 2023$215K$226K—
Q4 2022$65KNot machine-readable—
Q3 2022$166KNot machine-readable—
Q4 2021$51KNot machine-readable—
Q1 2021$315KNot machine-readable—
Q3 2020$182KNot machine-readable—

Form 144 notices went onto EDGAR as structured data on April 13, 2023. Earlier notices were filed on paper and cannot be read here, so those quarters show no noticed amount.

Planned sales (Form 144) and the sales that followed

Each Form 144 notice of a planned sale, grouped by broker and 10b5-1 plan, with the Form 4 sales we matched to it.

How we match

A Form 144 is a notice of a planned sale by an affiliate. SEC Tracker matches each notice to Form 4 sales by the same person at the same company within 90 days of the notice, up to the shares noticed. The match is our inference, not something either filing states.

Notice dateNoticedPlanned saleOutcomeLinks
Jazz Pharmaceuticals JAZZ · Etrade Financial · No 10b5-1 plan stated · 4 notices
Aug 31, 20263,507 · ~$858KAug 31, 2026Not sold yetFiling · EDGAR
Aug 8, 20253,731 · ~$418KAug 8, 2025Not sold within 90 daysFiling · EDGAR
Aug 5, 20243,075 · ~$341KAug 6, 2024Not sold within 90 daysFiling · EDGAR
Aug 14, 20232,561 · ~$346KAug 14, 2023Partly sold Sold 1,241 at $138.16 on Aug 14 · $171K likely match Form 4Filing · EDGAR
Jazz Pharmaceuticals JAZZ · Morgan Stanley Smith Barney · 10b5-1 plan adopted Mar 9, 2026 · 1 notice
Jun 15, 20261,157 · ~$267KJun 15, 2026Sold as noticed Sold 1,157 at $230.55 on Jun 15 · $267K Form 4Filing · EDGAR
Phreesia PHR · Fidelity Brokerage Services · 10b5-1 plan adopted Jan 10, 2025 · 1 notice
Jul 2, 20257,000 · ~$203KJul 2, 2025Sold as noticed Sold 7,000 at $29.00 on Jul 2 · $203K Form 4Filing · EDGAR
Phreesia PHR · Fidelity Brokerage Services · 10b5-1 plan adopted Dec 22, 2023 · 1 notice
Jul 18, 20247,000 · ~$175KJul 18, 2024Sold as noticed Sold 7,000 at $25.00 on Jul 18 · $175K Form 4Filing · EDGAR
Phreesia PHR · Morgan Stanley Smith Barney · 10b5-1 plan adopted Jan 18, 2023 · 1 notice
Apr 3, 20237,000 · ~$226KApr 3, 2023Sold as noticed Sold 7,000 in 2 sales, Apr 3 to Apr 3 · $215K Form 4Filing · EDGAR
Sales without a matching Form 144 · 8 sales
No matching Form 144 found. Not every sale needs one: small sales and sales by people who are not affiliates are exempt.
———Sold without notice Jazz Pharmaceuticals (JAZZ): Sold 417 at $119.27 on Dec 4, 2023 · $50KFiling · EDGAR
———Notice not machine-readable Jazz Pharmaceuticals (JAZZ): Sold 420 at $154.68 on Dec 2, 2022 · $65KFiling · EDGAR
———Notice not machine-readable Jazz Pharmaceuticals (JAZZ): Sold 1,089 at $152.32 on Aug 8, 2022 · $166KFiling · EDGAR
———Notice not machine-readable Jazz Pharmaceuticals (JAZZ): Sold 417 at $121.30 on Dec 2, 2021 · $51KFiling · EDGAR
———Notice not machine-readable Phreesia (PHR): Sold 300 at $54.06 on Jan 4, 2021 · $16K (10b5-1 plan)Filing · EDGAR
———Notice not machine-readable Phreesia (PHR): Sold 2,789 at $52.93 on Jan 4, 2021 · $148K (10b5-1 plan)Filing · EDGAR
———Notice not machine-readable Phreesia (PHR): Sold 2,911 at $52.07 on Jan 4, 2021 · $152K (10b5-1 plan)Filing · EDGAR
———Notice not machine-readable Phreesia (PHR): Sold 6,000 at $30.30 on Aug 10, 2020 · $182K (10b5-1 plan)Filing · EDGAR

Every transaction, by company

Each Form 3, 4 and 5 transaction in plain words, newest first.

How these figures work

Values are shares times the price each filing states; grants, exercises and gifts usually state no price. Held after is what the filing reports was held once the transaction was done, directly or through the named holder.

Jazz Pharmaceuticals JAZZ Director · filings 2020 to 2026 · sold $769K · $2.2M noticed on Form 144

DateTransactionSharesPriceValueHeld afterSource
Aug 31, 2026Shares withheld for tax or exercise price−14$244.64$3K11,271 directFiling · EDGAR
Aug 31, 2026Shares withheld for tax or exercise price−1,692$241.39$408K9,579 directFiling · EDGAR
Aug 5, 2026Grant or award from the company+1,60511,285 directFiling · EDGAR
Jun 15, 2026Sale under a 10b5-1 plan−1,157$230.55$267K9,680 directFiling · EDGAR
Aug 8, 2025Shares withheld for tax or exercise price−1,805$111.25$201K10,837 directFiling · EDGAR
Aug 7, 2025Grant or award from the company+3,50712,642 directFiling · EDGAR
Aug 6, 2024Shares withheld for tax or exercise price−1,484$111.35$165K9,135 directFiling · EDGAR
Aug 2, 2024Grant or award from the company+3,73110,619 directFiling · EDGAR
Dec 4, 2023Open-market or private sale−417$119.27$50K6,888 directFiling · EDGAR
Aug 14, 2023Open-market or private sale−1,241$138.16$171K7,305 directFiling · EDGAR
Aug 11, 2023Grant or award from the company+3,0758,546 directFiling · EDGAR
Dec 2, 2022Open-market or private sale−420$154.68$65K5,471 directFiling · EDGAR
Aug 8, 2022Open-market or private sale−1,089$152.32$166K5,891 directFiling · EDGAR
Aug 5, 2022Grant or award from the company+2,5616,980 directFiling · EDGAR
Dec 2, 2021Open-market or private sale−417$121.30$51K4,419 directFiling · EDGAR
Jul 29, 2021Grant or award from the company+2,2464,836 directFiling · EDGAR
Feb 25, 2021Grant or award from the company+2,5902,590 directFiling · EDGAR
Feb 25, 2021Grant or award from the company
Non-Qualified Stock Option (right to buy)
+6,4756,475 directFiling · EDGAR

Phreesia PHR Director · filings 2019 to 2026 · sold $1.1M · $604K noticed on Form 144

DateTransactionSharesPriceValueHeld afterSource
Jun 24, 2026Grant or award from the company+19,290$9.59$185K56,643 directFiling · EDGAR
Jul 2, 2025Option or RSU exercised or converted+7,000$4.71$33K44,353 directFiling · EDGAR
Jul 2, 2025Sale under a 10b5-1 plan−7,000$29.00$203K37,353 directFiling · EDGAR
Jul 2, 2025Option or RSU exercised or converted
Stock Option
−7,00051,193 directFiling · EDGAR
Jun 25, 2025Grant or award from the company+6,700$27.61$185K37,353 directFiling · EDGAR
Jul 18, 2024Option or RSU exercised or converted+7,000$4.71$33K37,653 directFiling · EDGAR
Jul 18, 2024Sale under a 10b5-1 plan−7,000$25.00$175K30,653 directFiling · EDGAR
Jul 18, 2024Option or RSU exercised or converted
Stock Option
−7,00058,193 directFiling · EDGAR
Jun 26, 2024Grant or award from the company+8,49030,653 directFiling · EDGAR
Jun 28, 2023Grant or award from the company+6,05122,163 directFiling · EDGAR
Apr 3, 2023Option or RSU exercised or converted+7,000$4.71$33K23,112 directFiling · EDGAR
Apr 3, 2023Sale under a 10b5-1 plan−6,500$30.69$199K16,612 directFiling · EDGAR
Apr 3, 2023Sale under a 10b5-1 plan−500$31.77$16K16,112 directFiling · EDGAR
Apr 3, 2023Option or RSU exercised or converted
Stock Option
−7,00065,193 directFiling · EDGAR
Jun 30, 2022Grant or award from the company+7,39716,112 directFiling · EDGAR
Jul 8, 2021Grant or award from the company+2,6058,715 directFiling · EDGAR
Jan 4, 2021Option or RSU exercised or converted+6,000$4.71$28K12,110 directFiling · EDGAR
Jan 4, 2021Sale under a 10b5-1 plan−2,911$52.07$152K9,199 directFiling · EDGAR
Jan 4, 2021Sale under a 10b5-1 plan−2,789$52.93$148K6,410 directFiling · EDGAR
Jan 4, 2021Sale under a 10b5-1 plan−300$54.06$16K6,110 directFiling · EDGAR
Jan 4, 2021Option or RSU exercised or converted
Stock Option (Right to Buy)
−6,00072,193 directFiling · EDGAR
Aug 10, 2020Option or RSU exercised or converted+6,000$4.71$28K12,110 directFiling · EDGAR
Aug 10, 2020Sale under a 10b5-1 plan−6,000$30.30$182K6,110 directFiling · EDGAR
Aug 10, 2020Option or RSU exercised or converted
Stock Option (Right to Buy)
−6,00078,193 directFiling · EDGAR
Jul 8, 2020Grant or award from the company+6,1106,110 directFiling · EDGAR

Teladoc Health TDOC Director · filings 2018 to 2026 · bought $28K

DateTransactionSharesPriceValueHeld afterSource
May 21, 2026Grant or award from the company
Restricted Stock Units
+30,44130,441 directFiling · EDGAR
May 22, 2025Grant or award from the company
Restricted Stock Units
+28,98628,986 directFiling · EDGAR
Aug 15, 2024Open-market or private purchase+4,000$7.08$28K8,355 directFiling · EDGAR
May 23, 2024Grant or award from the company
Restricted Stock Units
+17,46717,467 directFiling · EDGAR
May 25, 2023Grant or award from the company
Restricted Stock Units
+9,8349,834 directFiling · EDGAR
May 26, 2022Grant or award from the company
Restricted Stock Units
+6,7266,726 directFiling · EDGAR
May 17, 2022Option or RSU exercised or converted+8194,355 directFiling · EDGAR
May 17, 2022Option or RSU exercised or converted
Restricted Stock Units
−819819 directFiling · EDGAR
May 17, 2021Grant or award from the company
Restricted Stock Units
+1,6381,638 directFiling · EDGAR
May 14, 2021Option or RSU exercised or converted+5243,536 directFiling · EDGAR
May 14, 2021Option or RSU exercised or converted
Restricted Stock Units
−524525 directFiling · EDGAR
May 28, 2020Option or RSU exercised or converted+3,0123,012 directFiling · EDGAR
May 28, 2020Option or RSU exercised or converted
Restricted Stock Units
−3,0120 directFiling · EDGAR
May 28, 2020Grant or award from the company
Restricted Stock Units
+1,0491,049 directFiling · EDGAR
May 30, 2019Grant or award from the company
Restricted Stock Units
+3,0123,012 directFiling · EDGAR
All 45 Forms 3, 4, 5 and 144
FiledFormCompanyLinks
Sep 2, 2026Form 4Jazz Pharmaceuticals JAZZFiling · EDGAR
Aug 31, 2026Form 144Jazz Pharmaceuticals JAZZFiling · EDGAR
Aug 7, 2026Form 4Jazz Pharmaceuticals JAZZFiling · EDGAR
Jun 26, 2026Form 4Phreesia PHRFiling · EDGAR
Jun 17, 2026Form 4Jazz Pharmaceuticals JAZZFiling · EDGAR
Jun 15, 2026Form 144Jazz Pharmaceuticals JAZZFiling · EDGAR
May 21, 2026Form 4Teladoc Health TDOCFiling · EDGAR
Aug 11, 2025Form 4Jazz Pharmaceuticals JAZZFiling · EDGAR
Aug 8, 2025Form 144Jazz Pharmaceuticals JAZZFiling · EDGAR
Jul 3, 2025Form 4Phreesia PHRFiling · EDGAR
Jul 2, 2025Form 144Phreesia PHRFiling · EDGAR
Jun 27, 2025Form 4Phreesia PHRFiling · EDGAR
May 23, 2025Form 4Teladoc Health TDOCFiling · EDGAR
Aug 19, 2024Form 4Teladoc Health TDOCFiling · EDGAR
Aug 6, 2024Form 4Jazz Pharmaceuticals JAZZFiling · EDGAR
Aug 5, 2024Form 144Jazz Pharmaceuticals JAZZFiling · EDGAR
Jul 22, 2024Form 4Phreesia PHRFiling · EDGAR
Jul 18, 2024Form 144Phreesia PHRFiling · EDGAR
Jun 28, 2024Form 4Phreesia PHRFiling · EDGAR
May 24, 2024Form 4Teladoc Health TDOCFiling · EDGAR
Dec 6, 2023Form 4Jazz Pharmaceuticals JAZZFiling · EDGAR
Aug 15, 2023Form 4Jazz Pharmaceuticals JAZZFiling · EDGAR
Aug 14, 2023Form 144Jazz Pharmaceuticals JAZZFiling · EDGAR
Jun 30, 2023Form 4Phreesia PHRFiling · EDGAR
May 26, 2023Form 4Teladoc Health TDOCFiling · EDGAR
Apr 5, 2023Form 4Phreesia PHRFiling · EDGAR
Apr 3, 2023Form 144Phreesia PHRFiling · EDGAR
Dec 6, 2022Form 4Jazz Pharmaceuticals JAZZFiling · EDGAR
Aug 9, 2022Form 4Jazz Pharmaceuticals JAZZFiling · EDGAR
Jul 5, 2022Form 4Phreesia PHRFiling · EDGAR
May 31, 2022Form 4Teladoc Health TDOCFiling · EDGAR
May 18, 2022Form 4Teladoc Health TDOCFiling · EDGAR
Dec 6, 2021Form 4Jazz Pharmaceuticals JAZZFiling · EDGAR
Aug 2, 2021Form 4Jazz Pharmaceuticals JAZZFiling · EDGAR
Jul 12, 2021Form 4Phreesia PHRFiling · EDGAR
May 18, 2021Form 4Teladoc Health TDOCFiling · EDGAR
Mar 1, 2021Form 4Jazz Pharmaceuticals JAZZFiling · EDGAR
Jan 6, 2021Form 4Phreesia PHRFiling · EDGAR
Dec 3, 2020Form 3Jazz Pharmaceuticals JAZZFiling · EDGAR
Aug 12, 2020Form 4Phreesia PHRFiling · EDGAR
Jul 21, 2020Form 4Phreesia PHRFiling · EDGAR
Jun 1, 2020Form 4Teladoc Health TDOCFiling · EDGAR
Jul 17, 2019Form 3Phreesia PHRFiling · EDGAR
Jun 3, 2019Form 4Teladoc Health TDOCFiling · EDGAR
Oct 22, 2018Form 3Teladoc Health TDOCFiling · EDGAR

Every figure is as filed with the SEC on Forms 3, 4, 5 and 144. Holdings are the amounts reported after each person's latest filing at each company and can be out of date. Matching a Form 144 notice to Form 4 sales is SEC Tracker's inference from owner, company, dates and share counts, not something the filings state. Not investment advice. Not affiliated with the U.S. SEC.

Data on this page was fetched . The filing on SEC.gov is the record.